E-cigarette use among smokers with serious mental illness.

We examined electronic cigarette (EC) use, correlates of use, and associated changes in smoking behavior among smokers with serious mental illness in a clinical trial.Adult smokers were recruited during acute psychiatric hospitalization (N = 956, 73% enrollment among approached smokers) in the San F...

Full description

Bibliographic Details
Main Authors: Judith J Prochaska, Rachel A Grana
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4242512?pdf=render
id doaj-3abc2be54b2142e898cd9d05d00bd655
record_format Article
spelling doaj-3abc2be54b2142e898cd9d05d00bd6552020-11-25T01:49:45ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01911e11301310.1371/journal.pone.0113013E-cigarette use among smokers with serious mental illness.Judith J ProchaskaRachel A GranaWe examined electronic cigarette (EC) use, correlates of use, and associated changes in smoking behavior among smokers with serious mental illness in a clinical trial.Adult smokers were recruited during acute psychiatric hospitalization (N = 956, 73% enrollment among approached smokers) in the San Francisco Bay Area between 2009-2013. At baseline, participants averaged 17 (SD = 10) cigarettes per day for 19 (SD = 14) years; 24% intended to quit smoking in the next month. Analyses examined frequency and correlates of EC use reported over the 18-month trial and changes in smoking behavior by EC use status.EC use was 11% overall, and by year of enrollment, increased from 0% in 2009 to 25% in 2013. In multiple logistic regression, the likelihood of EC use was significantly greater with each additional year of recruitment, for those aged 18-26, and for those in the preparation versus precontemplation stage of change, and unlikely among Hispanic participants. EC use was unrelated to gender, psychiatric diagnosis, and measures of tobacco dependence at baseline. Further, over the 18-month trial, EC use was not associated with changes in smoking status or, among continued smokers, with reductions in cigarettes per day.Within a clinical trial with smokers with serious mental illness, EC use increased over time, particularly among younger adults and those intending to quit tobacco. EC use was unrelated to changes in smoking. The findings are of clinical interest and warrant further study.http://europepmc.org/articles/PMC4242512?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Judith J Prochaska
Rachel A Grana
spellingShingle Judith J Prochaska
Rachel A Grana
E-cigarette use among smokers with serious mental illness.
PLoS ONE
author_facet Judith J Prochaska
Rachel A Grana
author_sort Judith J Prochaska
title E-cigarette use among smokers with serious mental illness.
title_short E-cigarette use among smokers with serious mental illness.
title_full E-cigarette use among smokers with serious mental illness.
title_fullStr E-cigarette use among smokers with serious mental illness.
title_full_unstemmed E-cigarette use among smokers with serious mental illness.
title_sort e-cigarette use among smokers with serious mental illness.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description We examined electronic cigarette (EC) use, correlates of use, and associated changes in smoking behavior among smokers with serious mental illness in a clinical trial.Adult smokers were recruited during acute psychiatric hospitalization (N = 956, 73% enrollment among approached smokers) in the San Francisco Bay Area between 2009-2013. At baseline, participants averaged 17 (SD = 10) cigarettes per day for 19 (SD = 14) years; 24% intended to quit smoking in the next month. Analyses examined frequency and correlates of EC use reported over the 18-month trial and changes in smoking behavior by EC use status.EC use was 11% overall, and by year of enrollment, increased from 0% in 2009 to 25% in 2013. In multiple logistic regression, the likelihood of EC use was significantly greater with each additional year of recruitment, for those aged 18-26, and for those in the preparation versus precontemplation stage of change, and unlikely among Hispanic participants. EC use was unrelated to gender, psychiatric diagnosis, and measures of tobacco dependence at baseline. Further, over the 18-month trial, EC use was not associated with changes in smoking status or, among continued smokers, with reductions in cigarettes per day.Within a clinical trial with smokers with serious mental illness, EC use increased over time, particularly among younger adults and those intending to quit tobacco. EC use was unrelated to changes in smoking. The findings are of clinical interest and warrant further study.
url http://europepmc.org/articles/PMC4242512?pdf=render
work_keys_str_mv AT judithjprochaska ecigaretteuseamongsmokerswithseriousmentalillness
AT rachelagrana ecigaretteuseamongsmokerswithseriousmentalillness
_version_ 1725005237526200320